ClinicalTrialsFinder

Platinum-resistant Recurrent Ovarian Cancer Clinical Trials in Fuzhou

1 recruitingFuzhou, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer.

Platinum-resistant Recurrent Ovarian Cancer
Shanghai Jiaolian Drug Research and Development Co., Ltd90 enrolled17 locationsNCT06434610